FI960487A0 - Bentsopyraaneja ja niitä sisältäviä farmaseuttisia koostumuksia - Google Patents

Bentsopyraaneja ja niitä sisältäviä farmaseuttisia koostumuksia

Info

Publication number
FI960487A0
FI960487A0 FI960487A FI960487A FI960487A0 FI 960487 A0 FI960487 A0 FI 960487A0 FI 960487 A FI960487 A FI 960487A FI 960487 A FI960487 A FI 960487A FI 960487 A0 FI960487 A0 FI 960487A0
Authority
FI
Finland
Prior art keywords
benzopyrans
pharmaceutical compositions
disease
compounds
containing pharmaceutical
Prior art date
Application number
FI960487A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI960487A7 (fi
FI960487L (fi
Inventor
Alexander Roderick Mackenzie
Sandra Marina Monaghan
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of FI960487A7 publication Critical patent/FI960487A7/fi
Publication of FI960487L publication Critical patent/FI960487L/fi
Publication of FI960487A0 publication Critical patent/FI960487A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI960487A 1993-08-04 1994-07-18 Bentsopyraaneja ja niitä sisältäviä farmaseuttisia koostumuksia FI960487A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939316111A GB9316111D0 (en) 1993-08-04 1993-08-04 Benzopyrans
PCT/EP1994/002387 WO1995004730A1 (en) 1993-08-04 1994-07-18 Benzopyrans and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
FI960487A7 FI960487A7 (fi) 1996-02-02
FI960487L FI960487L (fi) 1996-02-02
FI960487A0 true FI960487A0 (fi) 1996-02-02

Family

ID=10739921

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960487A FI960487A0 (fi) 1993-08-04 1994-07-18 Bentsopyraaneja ja niitä sisältäviä farmaseuttisia koostumuksia

Country Status (28)

Country Link
US (2) US5912244A (cs)
EP (1) EP0712398B1 (cs)
JP (1) JP2871098B2 (cs)
KR (1) KR0175532B1 (cs)
CN (1) CN1128536A (cs)
AT (1) ATE152716T1 (cs)
AU (1) AU684817B2 (cs)
CA (1) CA2168563C (cs)
CO (1) CO4230234A1 (cs)
CZ (1) CZ281853B6 (cs)
DE (1) DE69403084T2 (cs)
DK (1) DK0712398T3 (cs)
EC (1) ECSP941140A (cs)
EG (1) EG20525A (cs)
ES (1) ES2102870T3 (cs)
FI (1) FI960487A0 (cs)
GB (1) GB9316111D0 (cs)
GR (1) GR3023521T3 (cs)
HU (1) HUT75120A (cs)
IL (1) IL110488A (cs)
NO (1) NO960441L (cs)
NZ (1) NZ271344A (cs)
PE (1) PE56894A1 (cs)
PL (1) PL312788A1 (cs)
SG (1) SG42817A1 (cs)
TW (1) TW333532B (cs)
WO (1) WO1995004730A1 (cs)
ZA (1) ZA945774B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5573758A (en) * 1995-04-28 1996-11-12 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
KR100314986B1 (ko) * 1996-06-07 2002-01-12 반더빌트유니버시티 항염증제로서 유용한 디히드로벤조피란및 관련화합물
US6333352B1 (en) * 2000-04-05 2001-12-25 Mimicking Man Manually, Inc. Method of treating benign positional vertigo
IL158262A0 (en) * 2001-04-16 2004-05-12 Schering Corp 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
CN1561338A (zh) * 2001-10-04 2005-01-05 惠氏公司 作为5-羟基色胺-6配体的苯并二氢吡喃衍生物
KR20050074592A (ko) * 2002-11-12 2005-07-18 워너-램버트 캄파니 엘엘씨 벤조피란을 사용한 모발 성장의 자극 방법
JP2007522201A (ja) * 2004-02-12 2007-08-09 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 毛成長の刺激方法
US20090110892A1 (en) * 2004-06-30 2009-04-30 General Electric Company System and method for making a graded barrier coating
WO2006008641A1 (en) * 2004-07-16 2006-01-26 Warner-Lambert Company Llc Hair growth promoting agents
MXPA06014390A (es) * 2004-07-19 2007-10-02 Warner Lambert Co Formulacion para estimular el crecimiento del pelo.
JP4738418B2 (ja) * 2004-12-21 2011-08-03 エフ.ホフマン−ラ ロシュ アーゲー クロマン誘導体及びcns障害の処置におけるその使用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3835011A1 (de) * 1988-10-14 1990-04-19 Merck Patent Gmbh Chromanderivate
DE3703227A1 (de) * 1987-02-04 1988-08-18 Hoechst Ag Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
DE3881714D1 (de) * 1987-02-04 1993-07-22 Hoechst Ag Alkylsubstituierte n-benzopyranyllactame, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen.
DE3811017A1 (de) * 1988-03-31 1989-10-19 Hoechst Ag Ungesaettigte n-benzopyranyllactame
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
EP0346724A1 (de) * 1988-06-16 1989-12-20 MERCK PATENT GmbH Chromanderivate
DE3824446A1 (de) * 1988-07-19 1990-01-25 Hoechst Ag, 6230 Frankfurt Verwendung substituierter 3,4-dihydro-2h-benzopyrane als heilmittel gegen obstruktive funktionsstoerungen der lunge und/oder stoerungen der ableitenden harnwege
DE3827532A1 (de) * 1988-08-13 1990-03-01 Hoechst Ag 6-aroyl-substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
DE3918041A1 (de) * 1989-06-02 1990-12-06 Merck Patent Gmbh Chromanderivate
US5061813A (en) * 1990-04-02 1991-10-29 E. R. Squibb & Sons, Inc. Substituted cyanoimino benzopyranes
GB2242628A (en) * 1990-04-06 1991-10-09 Sandoz Ltd Asthma prophylactic use of K+ channel activators
TW244350B (cs) * 1991-12-14 1995-04-01 Hoechst Ag
JPH0673061A (ja) * 1992-01-18 1994-03-15 Hoechst Ag 6−置換クロメン類のエナンチオ選択的エポキシ化方法

Also Published As

Publication number Publication date
TW333532B (en) 1998-06-11
IL110488A0 (en) 1994-10-21
FI960487A7 (fi) 1996-02-02
KR0175532B1 (ko) 1999-02-18
US5912244A (en) 1999-06-15
NZ271344A (en) 1997-10-24
CO4230234A1 (es) 1995-10-19
CZ281853B6 (cs) 1997-02-12
AU7494894A (en) 1995-02-28
ATE152716T1 (de) 1997-05-15
DK0712398T3 (da) 1997-10-27
JPH08508042A (ja) 1996-08-27
ES2102870T3 (es) 1997-08-01
WO1995004730A1 (en) 1995-02-16
IL110488A (en) 1999-08-17
US6071938A (en) 2000-06-06
DE69403084T2 (de) 1997-08-14
FI960487L (fi) 1996-02-02
SG42817A1 (en) 1997-10-17
GB9316111D0 (en) 1993-09-22
JP2871098B2 (ja) 1999-03-17
CA2168563C (en) 1999-09-07
ECSP941140A (es) 1995-01-16
DE69403084D1 (de) 1997-06-12
PL312788A1 (en) 1996-05-13
AU684817B2 (en) 1998-01-08
EG20525A (en) 1999-06-30
CA2168563A1 (en) 1995-02-16
NO960441D0 (no) 1996-02-02
EP0712398B1 (en) 1997-05-07
CZ33196A3 (en) 1996-05-15
PE56894A1 (es) 1995-02-07
CN1128536A (zh) 1996-08-07
HUT75120A (en) 1997-04-28
ZA945774B (en) 1996-02-05
EP0712398A1 (en) 1996-05-22
NO960441L (no) 1996-02-02
GR3023521T3 (en) 1997-08-29

Similar Documents

Publication Publication Date Title
BR0008015A (pt) Uso de um composto, composto, composições farmacêuticas, e, processo para preparar um composto
ATE203515T1 (de) Meta-substituierte phenylsulphonamidderivate
FI960487A0 (fi) Bentsopyraaneja ja niitä sisältäviä farmaseuttisia koostumuksia
ATE204857T1 (de) Meta-substituierte phenylenderivate und ihre verwendung als alphavbeta3 intergrin-antagonisten oder inhibitoren
DE69830504D1 (de) Antithrombotische mitteln
EA200100983A1 (ru) Производные 13-метилэритромицина
FI970317A0 (fi) Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä
NO964180D0 (no) Tropanderivater, deres fremstilling og anvendelse
EP0604354A3 (en) Antidepressant and anti-Parkinson's disease compounds.
FI902632A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 5-substitoitujen 5,11-dihydrodibentso/b,e//1,4/tiatsepiinijohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoisia välituotteita
NO20001198L (no) Pyrrolopyrrolondervater som inhibitorer av nøytrofil elastase
NO934760D0 (no) Arylsubstituerte heterosykliske forbindelser
DK0604355T3 (da) Arylsubstituerede heterocykliske forbindelser
NZ520155A (en) Thienopyridine derivatives, their production and use
ATE149159T1 (de) Heteroarylmethylbenzole-aromatasehemmer
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
DK0815109T3 (da) Fremgangsmåde til fremstilling af estere af anhydroecgonin
FI922518A7 (fi) Menetelmä farmaseuttisesti käyttökelpoisten pilokarpiinijohdannaisten valmistamiseksi